Tianda Pharmaceuticals Ltd banner
T

Tianda Pharmaceuticals Ltd
HKEX:455

Watchlist Manager
Tianda Pharmaceuticals Ltd
HKEX:455
Watchlist
Price: 0.11 HKD 1.85% Market Closed
Market Cap: HK$236.5m

Cash Flow Statement

Cash Flow Statement
Tianda Pharmaceuticals Ltd

Rotate your device to view
Cash Flow Statement
Currency: HKD
Mar-2002 Sep-2002 Mar-2003 Sep-2003 Mar-2004 Sep-2004 Mar-2005 Sep-2005 Mar-2006 Sep-2006 Mar-2007 Sep-2007 Mar-2008 Sep-2008 Mar-2009 Sep-2009 Mar-2010 Sep-2010 Mar-2011 Sep-2011 Mar-2012 Sep-2012 Mar-2013 Sep-2013 Mar-2014 Sep-2014 Mar-2015 Sep-2015 Mar-2016 Sep-2016 Mar-2017 Sep-2017 Mar-2018 Sep-2018 Mar-2019 Sep-2019 Mar-2020 Sep-2020 Mar-2021 Sep-2021 Mar-2022 Sep-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024 Dec-2024
Operating Cash Flow
Net Income
6
0
(5)
0
(5)
0
(0)
0
7
0
(37)
0
(110)
0
19
0
51
0
120
0
80
0
68
0
49
0
(23)
7
13
23
25
0
30
0
26
0
16
0
(27)
0
(28)
0
(48)
0
(26)
0
(54)
Depreciation & Amortization
1
0
0
0
1
0
2
0
2
0
3
0
3
0
4
0
3
0
11
0
24
0
19
0
18
0
19
11
21
21
21
0
22
0
16
0
20
0
21
0
22
0
38
0
36
0
38
Other Non-Cash Items
(6)
0
(0)
0
(3)
0
(2)
0
(8)
0
36
0
120
0
(1)
0
(11)
0
(44)
0
(13)
0
(22)
0
(2)
0
(5)
(2)
(3)
(9)
(5)
0
(12)
0
(5)
0
(5)
0
(4)
0
(11)
0
7
0
2
0
2
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
(0)
0
2
0
3
0
9
0
14
0
24
0
(0)
0
19
0
5
9
11
13
11
0
12
0
12
0
7
0
4
0
10
0
0
0
(0)
0
6
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
3
8
4
6
6
5
0
5
Change in Working Capital
4
(4)
(0)
(15)
1
(2)
(2)
(0)
(2)
1
1
12
3
12
(9)
17
(4)
58
(36)
69
(24)
114
63
67
(7)
10
(7)
(1)
(18)
(32)
(4)
36
19
51
(18)
(32)
(50)
(13)
(27)
(39)
9
(11)
80
27
(63)
(26)
4
Cash from Operating Activities
4
N/A
(4)
N/A
(5)
-31%
(15)
-188%
(6)
+61%
(2)
+61%
(1)
+41%
(0)
+92%
(1)
-700%
1
N/A
3
+86%
12
+350%
16
+38%
12
-25%
13
+4%
17
+37%
39
+125%
58
+50%
51
-12%
69
+35%
66
-4%
114
+72%
128
+12%
67
-48%
58
-13%
10
-84%
(16)
N/A
14
N/A
13
-3%
3
-78%
37
+1 182%
59
+59%
59
-1%
51
-13%
19
-62%
(32)
N/A
(20)
+38%
(13)
+37%
(38)
-199%
(39)
-5%
(8)
+79%
(11)
-30%
76
N/A
23
-70%
(50)
N/A
(26)
+48%
(10)
+63%
Investing Cash Flow
Capital Expenditures
(0)
0
(1)
0
(3)
0
(2)
0
(2)
(4)
(5)
(1)
(1)
0
(5)
0
(3)
0
(7)
0
(16)
0
(18)
0
(29)
(28)
(35)
(8)
(4)
(2)
(3)
(5)
(9)
(11)
(34)
(62)
(102)
(128)
(146)
(108)
(46)
(46)
(24)
(64)
(66)
(42)
(43)
Other Items
(11)
3
10
9
6
11
4
4
7
5
(12)
(14)
(41)
(39)
(24)
3
63
(182)
(205)
16
5
(116)
(53)
(4)
(1)
11
37
(25)
(64)
(23)
9
14
32
24
(47)
15
61
(26)
9
30
133
119
15
(14)
(3)
21
11
Cash from Investing Activities
(11)
N/A
3
N/A
9
+203%
9
+5%
4
-61%
11
+194%
2
-78%
4
+52%
6
+60%
1
-88%
(17)
N/A
(15)
+10%
(43)
-181%
(40)
+5%
(30)
+26%
3
N/A
60
+2 188%
(182)
N/A
(212)
-17%
16
N/A
(11)
N/A
(116)
-913%
(71)
+39%
(4)
+94%
(29)
-581%
(17)
+41%
2
N/A
(33)
N/A
(68)
-105%
(25)
+63%
6
N/A
8
+34%
23
+187%
13
-44%
(81)
N/A
(47)
+42%
(41)
+13%
(153)
-274%
(138)
+10%
(78)
+43%
86
N/A
73
-15%
(10)
N/A
(77)
-706%
(69)
+11%
(21)
+69%
(32)
-50%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
195
0
0
0
0
0
0
0
0
109
109
0
0
0
(0)
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
Net Issuance of Debt
0
0
0
0
(1)
0
0
0
2
0
1
0
0
0
4
0
0
0
2
0
(12)
0
0
0
0
0
(4)
0
0
0
0
0
0
0
0
(3)
16
58
100
76
8
4
(11)
(40)
(27)
(11)
(25)
Cash Paid for Dividends
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(4)
(26)
(26)
(9)
(9)
(2)
(8)
(10)
(4)
0
0
(5)
(6)
(12)
(10)
(7)
(7)
(17)
(2)
12
(3)
(5)
(9)
(21)
(18)
(18)
(6)
(8)
(6)
Other
0
0
0
1
1
(2)
0
0
(1)
2
0
(2)
54
63
0
(3)
(24)
171
1
(11)
(24)
(26)
(4)
(30)
(28)
(0)
5
1
(28)
(31)
(11)
(9)
(14)
0
0
0
(15)
(21)
(7)
0
(1)
(1)
0
0
(25)
0
0
Cash from Financing Activities
0
N/A
0
N/A
0
N/A
1
N/A
(0)
N/A
(2)
-350%
0
N/A
0
N/A
1
N/A
2
+163%
1
-38%
(2)
N/A
54
N/A
63
+16%
4
-94%
(3)
N/A
(24)
-840%
171
N/A
195
+14%
(37)
N/A
(62)
-66%
(35)
+43%
(13)
+63%
(32)
-150%
(36)
-11%
(10)
+71%
(3)
+69%
111
N/A
81
-26%
(35)
N/A
(17)
+51%
(21)
-19%
(24)
-18%
(21)
+15%
(7)
+66%
(19)
-179%
(1)
+96%
49
N/A
91
+86%
71
-22%
(1)
N/A
(18)
-1 276%
(29)
-62%
(58)
-101%
(57)
+1%
(44)
+23%
(31)
+30%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
1
1
4
4
1
0
0
2
6
8
3
2
(1)
(1)
(0)
(0)
1
(8)
(17)
(20)
(21)
(2)
36
(13)
(31)
(9)
(19)
11
21
14
9
(26)
(32)
(32)
(2)
(6)
(5)
Net Change in Cash
(6)
N/A
(1)
+84%
4
N/A
(4)
N/A
(3)
+40%
7
N/A
1
-85%
4
+270%
6
+59%
4
-29%
(12)
N/A
(4)
+63%
31
N/A
39
+24%
(12)
N/A
18
N/A
75
+323%
49
-34%
40
-19%
55
+38%
(4)
N/A
(35)
-889%
43
N/A
29
-33%
(8)
N/A
(19)
-143%
(17)
+10%
83
N/A
10
-88%
(77)
N/A
5
N/A
45
+800%
94
+108%
30
-68%
(100)
N/A
(108)
-8%
(81)
+25%
(106)
-31%
(64)
+40%
(33)
+49%
86
N/A
19
-78%
6
-67%
(144)
N/A
(178)
-23%
(97)
+45%
(77)
+21%
Free Cash Flow
Free Cash Flow
4
N/A
(4)
N/A
(7)
-67%
(15)
-126%
(8)
+43%
(2)
+74%
(3)
-27%
(0)
+96%
(2)
-2 300%
(3)
-17%
(3)
+11%
10
N/A
15
+42%
12
-18%
7
-40%
17
+136%
36
+107%
58
+63%
45
-23%
69
+55%
50
-27%
114
+127%
110
-4%
67
-39%
29
-57%
(19)
N/A
(52)
-176%
6
N/A
10
+71%
1
-93%
34
+4 811%
54
+56%
50
-7%
40
-20%
(14)
N/A
(94)
-548%
(122)
-30%
(140)
-15%
(184)
-31%
(148)
+20%
(55)
+63%
(57)
-4%
52
N/A
(41)
N/A
(116)
-185%
(68)
+41%
(52)
+23%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett